Abstract Details

Title IS SEVERITY OF ADVERSE EVENTS AFFECTED BY THE DOSE AND FREQUENCY OF GLATIRAMER ACETATE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS?

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 177

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Francisco Zagmutt PRESENTER	No disclosure on file
Ying Wu	No disclosure on file
Augusto Grinspan, MD (Acorda Therapeutics, Inc.)	Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Scott Kolodny, MD (Teva Pharmaceuticals)	No disclosure on file
Sanjay Gandhi, MD (Teva Pharmaceuticals)	Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.

��ɫ��